Frontiers in Pediatrics (Feb 2022)

PCRRT Expert Committee ICONIC Position Paper on Prescribing Kidney Replacement Therapy in Critically Sick Children With Acute Liver Failure

  • Rupesh Raina,
  • Rupesh Raina,
  • Sidharth K. Sethi,
  • Guido Filler,
  • Shina Menon,
  • Aliza Mittal,
  • Amrit Khooblall,
  • Amrit Khooblall,
  • Amrit Khooblall,
  • Prajit Khooblall,
  • Prajit Khooblall,
  • Ronith Chakraborty,
  • Ronith Chakraborty,
  • Ronith Chakraborty,
  • Harsha Adnani,
  • Nina Vijayvargiya,
  • Nina Vijayvargiya,
  • Sharon Teo,
  • Girish Bhatt,
  • Lee Jin Koh,
  • Chebl Mourani,
  • Marcelo de Sousa Tavares,
  • Khalid Alhasan,
  • Michael Forbes,
  • Maninder Dhaliwal,
  • Veena Raghunathan,
  • Dieter Broering,
  • Azmeri Sultana,
  • Giovanni Montini,
  • Giovanni Montini,
  • Patrick Brophy,
  • Mignon McCulloch,
  • Timothy Bunchman,
  • Hui Kim Yap,
  • Hui Kim Yap,
  • Rezan Topalglu,
  • Maria Díaz-González de Ferris

DOI
https://doi.org/10.3389/fped.2021.833205
Journal volume & issue
Vol. 9

Abstract

Read online

Management of acute liver failure (ALF) and acute on chronic liver failure (ACLF) in the pediatric population can be challenging. Kidney manifestations of liver failure, such as hepatorenal syndrome (HRS) and acute kidney injury (AKI), are increasingly prevalent and may portend a poor prognosis. The overall incidence of AKI in children with ALF has not been well-established, partially due to the difficulty of precisely estimating kidney function in these patients. The true incidence of AKI in pediatric patients may still be underestimated due to decreased creatinine production in patients with advanced liver dysfunction and those with critical conditions including shock and cardiovascular compromise with poor kidney perfusion. Current treatment for kidney dysfunction secondary to liver failure include conservative management, intravenous fluids, and kidney replacement therapy (KRT). Despite the paucity of evidence-based recommendations concerning the application of KRT in children with kidney dysfunction in the setting of ALF, expert clinical opinions have been evaluated regarding the optimal modalities and timing of KRT, dialysis/replacement solutions, blood and dialysate flow rates and dialysis dose, and anticoagulation methods.

Keywords